Concomitant chemoradiation for head and neck cancer: Saving lives or grays?

被引：5

作者：

Henk, JM ^{[1
]}

机构：

[1] Royal Marsden Hosp, London SW3 6JJ, England

来源：

CLINICAL ONCOLOGY | 2001年 / 13卷 / 05期

关键词：

D O I：

10.1007/s001740170030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：333 / 335

页数：3

共 14 条

[1] Concomitant bid radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: Clinical and pharmacological data of a French multicenter phase II study [J].

Bensadoun, RJ ;

Etienne, MC ;

Dassonville, O ;

Chauvel, P ;

Pivot, X ;

Marcy, PY ;

Prevost, B ;

Coche-Dequeant, B ;

Bourdin, S ;

Vallicioni, J ;

Poissonnet, G ;

Courdi, A ;

Teissier, E ;

Lagrange, JL ;

Thyss, A ;

Santini, J ;

Demard, F ;

Schneider, M ;

Milano, G .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (02) :237-245

[2] SOME OBSERVATIONS ON COMBINED EFFECTS OF X-RAYS AND METHOTREXATE ON HUMAN TUMOR CELLS IN VITRO WITH POSSIBLE RELEVANCE TO THEIR MOST USEFUL COMBINATION IN RADIOTHERAPY [J].

BERRY, RJ .

AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1968, 102 (03) :509-&

[3] Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer [J].

Brizel, DM ;

Albers, ME ;

Fisher, SR ;

Scher, RL ;

Richtsmeier, WJ ;

Hars, V ;

George, SL ;

Huang, AT ;

Prosnitz, LR .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) :1798-1804

[4] A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 [J].

Fu, KK ;

Pajak, TF ;

Trotti, A ;

Jones, CU ;

Spencer, SA ;

Phillips, TL ;

Garden, AS ;

Ridge, JA ;

Cooper, JS ;

Ang, KK .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :7-16

[5]

GRAU C, 2001, RADIOTHERAPY ONCO S1, V58, pS16

[6] Concomitant methotrexate and radiotherapy in advanced head and neck cancer: 15-year follow-up of a randomized clinical trial [J].

Gupta, NK ;

Swindell, R .

CLINICAL ONCOLOGY, 2001, 13 (05) :339-344

[7]

Henk J M, 1997, Clin Oncol (R Coll Radiol), V9, P308, DOI 10.1016/S0936-6555(05)80064-0

[8] HYPERFRACTIONATED COMPARED WITH CONVENTIONAL RADIOTHERAPY IN OROPHARYNGEAL CARCINOMA - AN EORTC RANDOMIZED TRIAL [J].

HORIOT, JC ;

LEFUR, R ;

NGUYEN, T ;

CHENAL, C ;

SCHRAUB, S ;

ALFONSI, S ;

GARDANI, G ;

VANDENBOGAERT, W ;

DANCZAK, S ;

BOLLA, M ;

VANGLABBEKE, M ;

DEPAUW, M .

EUROPEAN JOURNAL OF CANCER, 1990, 26 (07) :779-780

[9] A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma, results of the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85 [J].

Overgaard, J ;

Hansen, HS ;

Overgaard, M ;

Bastholt, L ;

Berthelsen, A ;

Specht, L ;

Lindelov, B ;

Jorgensen, K .

RADIOTHERAPY AND ONCOLOGY, 1998, 46 (02) :135-146

[10]

OVERGAARD J, 2001, RADIOTHER ONCOL S1, V58, pS40

← 1 2 →